Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study
Constantine Scordalakes,1 Robert delRosario,2 Andrew Shimer,3 Russell Stankiewicz4 1Women’s Health Care, P.C., Newburgh, IN, 2Partners in Women’s Healthcare, Lemoyne, PA, 3Craig Ranch OB-GYN, McKinney, TX, 4OB-GYN of Evangelical, Lewisburg, PA, USA Objective: Compare amenorrhea...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | International Journal of Women's Health |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-patient-satisfaction-after-novasure-and-minerva-endometri-peer-reviewed-article-IJWH |
id |
doaj-b987aa2c5e6f4c008a61b71266e395c6 |
---|---|
record_format |
Article |
spelling |
doaj-b987aa2c5e6f4c008a61b71266e395c62020-11-25T00:00:28ZengDove Medical PressInternational Journal of Women's Health1179-14112018-04-01Volume 1013714537850Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative studyScordalakes CdelRosario RShimer AStankiewicz RConstantine Scordalakes,1 Robert delRosario,2 Andrew Shimer,3 Russell Stankiewicz4 1Women’s Health Care, P.C., Newburgh, IN, 2Partners in Women’s Healthcare, Lemoyne, PA, 3Craig Ranch OB-GYN, McKinney, TX, 4OB-GYN of Evangelical, Lewisburg, PA, USA Objective: Compare amenorrhea rate, menstrual symptoms, patient satisfaction, and adverse events in women who underwent endometrial ablation with the NovaSure versus the Minerva radiofrequency ablation systems.Methods: We surveyed 189 premenopausal women (mean 40.8±6.2 years old) who underwent endometrial ablation for abnormal uterine bleeding using the NovaSure (n=97) or Minerva (n=92) systems, at four private US gynecology clinics, and whose procedure date was after July 2015 with follow-up ≥3 months. Women were surveyed an average of 11.3±3.9 months (range 137–532 days) after ablation.Results: The subject-reported amenorrhea rate was 52% higher in NovaSure subjects than Minerva subjects (64% and 42%, respectively; p=0.004). Age and bleeding cyclicity did not affect amenorrhea rate in either group. Normal-to-no bleeding was reported by >90% of subjects after either treatment. NovaSure was significantly more effective than Minerva at reducing pad/tampon use in women with any residual bleeding (2.4±5.2 items/day versus 4.7±5.5 items/day, p=0.049). NovaSure was significantly more effective than Minerva at reducing premenstrual syndrome (PMS) symptoms (p=0.019) and menstrual pain (p=0.003), and more NovaSure subjects (94%) than Minerva subjects (78%) were satisfied with clinical outcomes (p=0.003). Adverse events did not differ by treatment; three women in each group progressed to hysterectomy.Conclusion: While overall bleeding reduction in premenopausal women with abnormal uterine bleeding was excellent with either endometrial ablation system, NovaSure treatment resulted in a higher patient-reported 1-year amenorrhea rate, and women with residual bleeding used fewer pads and tampons than Minerva-treated women. Additionally, NovaSure subjects reported better menstrual-related life quality and PMS symptom alleviation, and greater satisfaction with outcomes than Minerva-treated women. Keywords: endometrial ablation, abnormal uterine bleeding, NovaSure, Minerva, premenopausal, satisfactionhttps://www.dovepress.com/efficacy-and-patient-satisfaction-after-novasure-and-minerva-endometri-peer-reviewed-article-IJWHEndometrial ablationAbnormal uterine bleedingNovaSureMinervaPremenopausalSatisfaction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Scordalakes C delRosario R Shimer A Stankiewicz R |
spellingShingle |
Scordalakes C delRosario R Shimer A Stankiewicz R Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study International Journal of Women's Health Endometrial ablation Abnormal uterine bleeding NovaSure Minerva Premenopausal Satisfaction |
author_facet |
Scordalakes C delRosario R Shimer A Stankiewicz R |
author_sort |
Scordalakes C |
title |
Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study |
title_short |
Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study |
title_full |
Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study |
title_fullStr |
Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study |
title_full_unstemmed |
Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study |
title_sort |
efficacy and patient satisfaction after novasure and minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study |
publisher |
Dove Medical Press |
series |
International Journal of Women's Health |
issn |
1179-1411 |
publishDate |
2018-04-01 |
description |
Constantine Scordalakes,1 Robert delRosario,2 Andrew Shimer,3 Russell Stankiewicz4 1Women’s Health Care, P.C., Newburgh, IN, 2Partners in Women’s Healthcare, Lemoyne, PA, 3Craig Ranch OB-GYN, McKinney, TX, 4OB-GYN of Evangelical, Lewisburg, PA, USA Objective: Compare amenorrhea rate, menstrual symptoms, patient satisfaction, and adverse events in women who underwent endometrial ablation with the NovaSure versus the Minerva radiofrequency ablation systems.Methods: We surveyed 189 premenopausal women (mean 40.8±6.2 years old) who underwent endometrial ablation for abnormal uterine bleeding using the NovaSure (n=97) or Minerva (n=92) systems, at four private US gynecology clinics, and whose procedure date was after July 2015 with follow-up ≥3 months. Women were surveyed an average of 11.3±3.9 months (range 137–532 days) after ablation.Results: The subject-reported amenorrhea rate was 52% higher in NovaSure subjects than Minerva subjects (64% and 42%, respectively; p=0.004). Age and bleeding cyclicity did not affect amenorrhea rate in either group. Normal-to-no bleeding was reported by >90% of subjects after either treatment. NovaSure was significantly more effective than Minerva at reducing pad/tampon use in women with any residual bleeding (2.4±5.2 items/day versus 4.7±5.5 items/day, p=0.049). NovaSure was significantly more effective than Minerva at reducing premenstrual syndrome (PMS) symptoms (p=0.019) and menstrual pain (p=0.003), and more NovaSure subjects (94%) than Minerva subjects (78%) were satisfied with clinical outcomes (p=0.003). Adverse events did not differ by treatment; three women in each group progressed to hysterectomy.Conclusion: While overall bleeding reduction in premenopausal women with abnormal uterine bleeding was excellent with either endometrial ablation system, NovaSure treatment resulted in a higher patient-reported 1-year amenorrhea rate, and women with residual bleeding used fewer pads and tampons than Minerva-treated women. Additionally, NovaSure subjects reported better menstrual-related life quality and PMS symptom alleviation, and greater satisfaction with outcomes than Minerva-treated women. Keywords: endometrial ablation, abnormal uterine bleeding, NovaSure, Minerva, premenopausal, satisfaction |
topic |
Endometrial ablation Abnormal uterine bleeding NovaSure Minerva Premenopausal Satisfaction |
url |
https://www.dovepress.com/efficacy-and-patient-satisfaction-after-novasure-and-minerva-endometri-peer-reviewed-article-IJWH |
work_keys_str_mv |
AT scordalakesc efficacyandpatientsatisfactionafternovasureandminervaendometrialablationfortreatingabnormaluterinebleedingaretrospectivecomparativestudy AT delrosarior efficacyandpatientsatisfactionafternovasureandminervaendometrialablationfortreatingabnormaluterinebleedingaretrospectivecomparativestudy AT shimera efficacyandpatientsatisfactionafternovasureandminervaendometrialablationfortreatingabnormaluterinebleedingaretrospectivecomparativestudy AT stankiewiczr efficacyandpatientsatisfactionafternovasureandminervaendometrialablationfortreatingabnormaluterinebleedingaretrospectivecomparativestudy |
_version_ |
1725444857368936448 |